Tofacitinib 5 mg Tablets are an advanced disease-modifying antirheumatic medication (DMARD) used to treat rheumatoid arthritis and psoriatic arthritis. Tofacitinib works by inhibiting Janus Kinase (JAK) enzymes, which play a major role in the inflammatory process. By reducing inflammation at the cellular level, it helps decrease joint pain, stiffness, swelling, and prevents further joint damage. This medication significantly improves physical mobility, reduces flare-ups, and supports better long-term management of autoimmune inflammatory conditions. It is ideal for patients who have not responded well to conventional DMARDs.
Tofacitinib 5 mg: A JAK inhibitor that reduces inflammatory pathways, relieves joint symptoms, improves mobility, and prevents structural joint damage in arthritis.
Powerful JAK Inhibitor for Arthritis: Targets the source of inflammation, offering stronger relief compared to traditional therapies.
Reduces Joint Pain, Swelling & Stiffness: Improves daily functioning and enhances overall quality of life.
Effective for Rheumatoid & Psoriatic Arthritis: Helps control autoimmune activity and reduces disease progression.
Suitable for Long-Term Management: Provides sustained control of arthritis symptoms and reduces flare-ups.
Take the tablet exactly as prescribed by a rheumatologist or healthcare professional. Do not self-adjust the dose. Regular monitoring may be required.
May include headache, increased cholesterol, mild stomach upset, or infections. Seek immediate medical attention if serious symptoms occur.
Globus Labs brings you WHO-GMP–certified, high-quality Tofacitinib sourced from reputed pharmaceutical manufacturers. Tofabet is formulated to deliver safe, potent, and clinically trusted support.
Whether you’re seeking a franchise opportunity, exploring wholesale distribution, or evaluating Globus Labs for international trade, we’re here to help you build a strong, profitable partnership. Let’s discuss how we can grow together and create meaningful value for your business.